F., Doyle, D
The method of embodiment 154, wherein the composition comprises between about 0.01% to about 20% by weight of the cholesterol, about 0.01% to about 15% by weight of the cholesterol, about 0.01% to about 10% by weight of the cholesterol, about 0.01% to about 7% by weight of the cholesterol, about 0.01% to about 5% by weight of the cholesterol, about 0.01% to about 3% by weight of the cholesterol, about 0.01% to about 2% by weight of the cholesterol, or about 0.01% to about 1% by weight of the cholesterol
Figure 2 The Mayo clinic group has proposed the fractional excretion of mannitol, rather than the LMR to evaluate small intestinal permeability (33, 37, 38)
Is particularly suitable for the treatment of respiratory issues, asthma, neurological function, pulmonary fibrosis
Certificate of Analysis available for batch transparency
European Journal of Endocrinology/European Federation of Endocrine Societies, 168 (5), 10.1530/EJE-12-1037